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Signaling involving PI3K and AKT regulates cell growth, partly through the mTOR kinase complexes 1 and 2.
In this issue of Cell Stem Cell, Kalaitzidis et al. and Magee et al. reveal unique requirements for mTORC1 and
mTORC2 signaling during blood development and leukemogenesis induced by loss of PTEN.Normal blood development depends
upon the regulated renewal and expan-
sion of hematopoietic stem cells (HSCs),
which give rise to progressively differenti-
ated cell types that ultimately constitute
circulating blood. Thus, aberrant regu-
lation of the signaling pathways that
underlie normal HSC renewal and differ-
entiation is one of the pathogenic hall-
marks of human leukemias. In particular,
members of the PI3K family of lipid
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Figure 1. Contribution of mTORC1 and mTORC2
Signaling to Normal Hematopoiesis and PTEN
Loss-Induced Leukemogenesis
PTEN negatively regulates PI3K-AKT signaling, which is
mediated in part by mTORC1 and mTORC2, multiprotein
complexes containing the mTOR kinase and specific sub-
strate recruitment factors Raptor and Rictor, respectively.phosphatidylinositol triphosphate
(PIP3) in response to extracellular
ligands and cell surface receptors,
including those involved in blood
development (Vanhaesebroeck
et al., 2010). In the human leuke-
mias, including T cell acute lympho-
blastic leukemia (T-ALL), PI3K
signaling is frequently activated as
a result of loss-of-function muta-
tions of the phosphatase PTEN,
which normally antagonizes PI3K
(Gutierrez et al., 2009; Song et al.,
2012). Production of PIP3 activates
AKT, as well as numerous down-
stream signaling mediators such
as the mTOR kinase, which is a
key component of two complexes,
mTORC1 and mTORC2 (Laplante
and Sabatini, 2012). These com-
plexes contain several shared pro-
teins, as well as unique components
such as the substrate recruitment
factors Raptor and Rictor, which
can be used to discriminate
between mTORC1 and mTORC2,
respectively.
Activation of PI3K-AKT signaling
in mouse blood cells, due to either
the loss of PTEN or mutational acti-vation of AKT, can induce HSC prolifera-
tion and depletion, and can lead to
T-ALL (Kharas et al., 2010; Yilmaz et al.,
2006; Zhang et al., 2006). However, the
individual contributions of mTORC1 and
mTORC2 to normal blood development
and the molecular pathogenesis of
T-ALL induced by PTEN loss are not well
understood. In this issue of Cell Stem
Cell, Kalaitzidis et al. and Magee et al.
now reveal the distinct roles of mTORC1
and mTORC2 during normal hematopoi-Cell Stem Cell 11, Sesis and leukemogenesis (Kalaitzidis
et al., 2012; Magee et al., 2012; Figure 1).
Through conditional inactivation of
Raptor and Rictor in genetically engi-
neered mice, these authors identify the
unique requirements for Raptor/mTORC1
andRictor/mTORC2 for HSC function and
PTEN loss-induced leukemogenesis. The
study by Kalatitzidis et al. used condi-
tional knockout mice for Raptor, Rictor,
or both factors to compare their roles
in HSC function. They found a nonredun-eptemdant requirement for Raptor in
HSC regeneration and also defined
a role for Raptor in PTEN loss-
induced leukemogenesis. Magee
et al. studied mice with a conditional
deletion of Rictor and found that
while loss of Rictor/mTORC2 had
little effect on normal HSC function,
Rictor-dependent mTORC2 sig-
naling is required for leukemogen-
esis in adult, but not neonatal,
HSCs lacking PTEN.
Both groups found that deletion of
Rictor leads to reduced mTORC2
activity, as judged by AKT S473
phosphorylation, with no effects
on the steady-state proliferation
of mouse HSCs, and only small
reductions in peripheral white
blood counts. Rictor-deficient cells
were also able to completely recon-
stitute irradiated mice, albeit with
slower kinetics than Rictor-profi-
cient controls.
In contrast to mice with condi-
tional inactivation of Rictor/
mTORC2, mice with deletion of
Raptor and consequent inactivation
of mTORC1 developed profound
pancytopenia (Kalaitzidis et al.,ber 7, 2012 ª2012 Elsevier Inc. 281
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Previews2012). These blood count changes were
associated with nearly complete loss
of HSC regenerative capacity, as deter-
mined from careful chimerism and trans-
plantation experiments. Hence, normal
hematopoiesis and HSC regeneration
appear to be primarily regulated by the
Raptor-dependent activities of mTORC1.
Loss of PTEN in HSCs, with conse-
quent activation of PI3K-AKT signaling,
leads to increased HSC cycling with
a deficiency in self-renewal and eventual
HSC depletion. These PTEN-deficient
HSCs give rise to abnormalities in
thymocyte progenitors, culminating in
the development of T-ALL. mTORC2
appears to be essential for the effects
of PTEN loss on both normal HSC self-
renewal and leukemogenesis, because
deletion of Rictor normalized HSC pro-
liferation and blocked T-ALL in the PTEN
null background (Magee et al., 2012).
Deletion of Raptor also significantly
reduced the incidence of T-ALL in PTEN-
deficient animals, indicating a nonredun-
dant requirement for both mTORC1 and
mTORC2 activities in leukemic transfor-
mation induced by PTEN loss (Kalaitzidis
et al., 2012).
Importantly, the studies by Kalaitzidis
et al. andMagee et al. establish a potential
therapeutic window for interfering with
leukemogenic PI3K-AKT signaling by282 Cell Stem Cell 11, September 7, 2012 ª2using specific blockade of Rictor-depen-
dent mTORC2 activities, which does not
appear to have significant effects on
steady-state and long-term regenerative
hematopoiesis in mice, yet substantially
impedes the development of T-ALL. Ther-
apeutic blockade of Raptor-dependent
mTORC1 activities in T-ALL driven by
PTEN loss is likely to bemore challenging,
as mTORC1 function is required to
sustain normal hematopoiesis.
Interestingly, HSCs from neonatal mice
appear to resist the effects of PTEN loss
on cell proliferation, and do not give rise
to T-ALL (Magee et al., 2012). PTEN-defi-
cient HSCs from neonatal mice show
reduced AKT activation as compared to
their adult counterparts, suggesting that
they are endowed with activities that limit
the production of PIP3 and/or activation
of AKT. Given that mTORC2 is required
for PTEN loss-induced leukemogenesis
and that mTORC2 can activate AKT, the
resistance of neonatal HSCs to the effects
of PTEN loss suggests the testable
hypothesis that mTORC2 may be physio-
logically suppressed during neonatal
development. Future studies to elucidate
the mechanisms underlying such sup-
pression, or perhaps alternative explana-
tions for lower levels of AKT activation
in both wild-type and PTEN-deficient
neonatal hematopoietic cells, may permit012 Elsevier Inc.the eventual ‘‘reprogramming’’ of hema-
topoietic cells to a state of PI3K non-
responsiveness, which could then be
exploited therapeutically.
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Recently in Nature, Song et al. (2012) show that the neurotransmitter GABA acts directly on radial glia-like
neural stem cells to maintain quiescence and provide a mechanism for how neuronal activity controls the
production of new neurons in the hippocampus.New neurons are continuously gener-
ated in the adult brain. Neural stem cells
(NSCs) in the subventricular zone (SVZ)
generate neurons for the olfactory
bulb, whereas NSCs in the subgranular
zone (SGZ) generate neurons for the
dentate gyrus of the hippocampus.NSCs transition between quiescence
and proliferation, allowing them to
respond to the dynamic needs of the
brain. The NSC niche is a major supplier
of the information NSCs need in order
to adapt to new situations and alter their
activity.The hippocampus is a structure impor-
tant for memory formation and cognition,
and hippocampal neurogenesis is known
to affect memory and learning. In the
SGZ, radial glia-like NSCs divide to
generate intermediate progenitors, which
then give rise to new neurons that
